3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Carcinoma, Renal Cell
2
Weight Loss
1
Triple Negative Breast Neoplasms
1
Sleep Apnea Syndromes
1
Sezary Syndrome
1
Sarcoma
1
Overweight
1
Obesity, Morbid
1
Obesity
1
Non-Muscle Invasive Bladder Neoplasms
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Hypertension
1
Hyperlipidemias
1
Hemangioma
1
Gastroesophageal Reflux
1
Eczema
1
Digestive System Diseases
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Dermatitis, Atopic
1
Collagen Diseases
1
Breast Neoplasms
1
Interventions
Blood Specimen Collection
5
Drug Therapy
3
Specimen Handling
2
Immune Checkpoint Inhibitors
2
Carboplatin
2
Biopsy, Large-Core Needle
2
Biopsy
2
toripalimab
1
tislelizumab
1
taxane
1
sacituzumab govitecan
1
pembrolizumab
1
atezolizumab
1
Zoledronic Acid
1
Urine Specimen Collection
1
Prophylactic Mastectomy
1
Paracentesis
1
Neuropsychological Tests
1
Mifepristone
1
Medicine, Chinese Traditional
1
Mastectomy, Segmental
1
Magnetic Resonance Spectroscopy
1
Interviews as Topic
1
Immunotherapy
1
Immunohistochemistry
1
Gene Expression Profiling
1
Doxorubicin
1
DNA
1
Cyclophosphamide
1
Combined Modality Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Triple Negative Breast Neoplasms
×
Urine Specimen Collection
×
Clear all
NCT04268693
2022-11-17
EDC-TNBC
George Washington University
Withdrawn